Latest News about Gene Editing
Recent news which mentions Gene Editing
Biotech ETF SBIO Sees Buy Signal Amid Hot Returns
December 14, 2023
From ETF Trends
Play US Gene Treatment Approval in SBIO
December 07, 2023
From ETF Trends
Bill Gates Gets Excited About Future Of Tech That Has 'Revolutionized Health' Over Past Decade
February 06, 2023
Tickers
TECH
From Benzinga
Beam Therapeutics Touts Encouraging Preclinical Data From Gene Editing Approach For Hepatitis B Infection
September 19, 2022
Tickers
BEAM
From Benzinga
From Benzinga
Editas Medicine Stock Jumps As Patent Office Rules In Favor Of Broad's CRISPR Patents
March 01, 2022
Tickers
EDIT
From Benzinga
From Benzinga
Pfizer, Beam Ink Multi-Target Research Collaboration For In Vivo Base Editing Programs
January 10, 2022
From Benzinga
Jennifer Doudna Spinout Mammoth Inks $700M CRISPR Deal With Vertex
October 26, 2021
Tickers
VRTX
From Benzinga
From Benzinga
Here's Why Editas Stock Dropped After Data From CRISPR-Based Retinal Disorder Candidate
September 29, 2021
Tickers
EDIT
From Benzinga
Wave Life Sciences Shows Durable ADAR-Editing In Multiple Tissues In Animal Studies
September 29, 2021
Tickers
WVE
From Benzinga
Beam Therapeutics' Base Editors Show Encouraging Preclinical Action In HBV Infection
September 27, 2021
Tickers
BEAM
From Benzinga
Beam Therapeutics' Formulated LNP Show Tolerance, Early Storage Stability In Animal Studies
September 23, 2021
Tickers
BEAM
From Benzinga
How Colossal sold investors on a quest to resurrect a woolly mammoth
September 13, 2021
Tickers
TC
From TechCrunch
Tickers
TC
From TechCrunch
Shape Therapeutics, Roche Form $3B RNA Editing Collaboration
August 24, 2021
From Benzinga
New Technologies Driving the Future of Plant Breeding
August 10, 2021
Graphite Bio's Approach To Gene Editing Has BofA Securities and Morgan Stanley Bullish
July 20, 2021
From Benzinga
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.